Particle.news

Download on the App Store

Comprehensive Review Finds Five OTC Supplements Backed by Strong Depression Trials

The study grades evidence from 209 clinical trials of herbal and dietary products, exposing major gaps in safety reporting and research scope.

Image
Potential or placebo? Research is lagging behind this growing market

Overview

  • St John’s Wort, saffron, probiotics, vitamin D and mixed omega-3s are the only products supported by more than ten depression trials each
  • Eighteen supplements including folic acid, lavender, zinc, tryptophan, rhodiola and lemon balm show emerging evidence with two to nine trials apiece
  • Over 40 products have only a single study or none, leaving common herbs such as ginseng, gingko and peppermint unevaluated for depressive symptoms
  • Just 69% of trials fully documented side effects, prompting calls for stricter safety protocols and comprehensive adverse-event reporting
  • Authors and experts urge new research on supplement use alongside talking therapies, health-service cost analyses and under-researched popular products